TITLE: PROSTATE CANCER
AUTHOR: ROBERT DREICER, MD -- Department of Hematology and Medical Oncology
REVISED: JANUARY 7, 2006
Table 1:
Summary of Current Prostate Cancer Guidelines From Selected Organizations
ACP-ASIM Physicians should describe potential benefits and known harms of screening,
diagnosis and treatment; listen to the patient's concerns, then individualize the
decision to screen.
ACS, AUA Offer annual DRE and PSA screening, beginning at age 50, to men who have at
least a 10-year life expectancy and to younger men at high risk.
CTFPHC and USPSTF DRE and PSA tests are not recommended for the general population.
AAFP No published standards or guidelines for low-risk patients.
AMA Provide information regarding the risks and potential benefits of prostate screening.
ACP-ASIM: American College of Physicians-American Society of Internal Medicine
ACS: American Cancer Society
AUA: American Urological Association
CTFPHC: Canadian Task Force on Preventive Health Care
USPSTF: U.S. Preventive Services Task Force
AAFP: American Academy of Family Physicians
AMA: American Medical Association
DRE: Digital Rectal Exam

 

Table 2:
TNM Clinical Stages
T1a Nonpalpable, with < 5% of tissue with cancer, low grade
(diagnosed by transurethral resection of the prostate)
T1b Nonpalpable, with > 5% of tissue with cancer and/or high grade (diagnosed by transurethral resection of the prostate)
T1c Nonpalpable, but prostate-specific antigen elevated
T2a Palpable, half of one lobe or less
T2b Palpable, more than half of one lobe, not both lobes
T2c Palpable, involves both lobes
T3a Palpable, unilateral capsular penetration
  

This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this web site.

Copyright 2005 The Cleveland Clinic Foundation